Latest California Healthline Stories
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Alec Raeshawn Smith was 23 when diagnosed with Type 1 diabetes, and 26 when he died. He couldn’t afford $1,300 per month for his insulin and other diabetes supplies. So he tried to stretch the doses.
California lawmakers approved 14 measures to address the opioid crisis, including one that requires health plans to cover medication-based treatments for opioid addiction without requiring pre-authorization. Gov. Jerry Brown has until the end of September to approve or reject the proposals.
Desperate for help in finding a lifesaving drug for a fatal genetic disease, families banded together to fund early research and then worked with drug companies on clinical trials and marketing. Yet, this small patient advocacy group is stunned by pharma’s pricing.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico talk about the latest court challenge to the Affordable Care Act, nomination hearings for Supreme Court nominee Brett Kavanaugh and news from the reproductive health front. Plus, Rovner interviews Chad Terhune about the latest KHN/NPR “Bill of the Month” installment.
Is there anything families can do to fight these evictions?
At least 11 states are going to try to tax opioids despite pushback from pharmaceutical companies.
No one tracks sepsis cases closely enough to know how often these severe infections turn fatal. But the toll — both human and financial — is enormous, finds an investigation by KHN and the Chicago Tribune.
California frequently innovates to address its wide-ranging health care needs, but it has not always achieved its aims. A series of articles in the journal Health Affairs shows, among other things, that efforts to care for HIV patients, provide better access to reproductive services for low-income women and fill gaps in primary care have sometimes fallen flat.
Post-9/11, Giuliani Partners helped craft a plan that put a halt to a probe into Purdue’s marketing of OxyContin.